Enacts provisions relating to insurance coverage for prescription insulin drugs

HB 3117 requires health insurance plans in the state to cap out-of-pocket costs for prescription insulin at $30 per 30-day supply for people with diabetes. It mandates that plans reduce the drug price by 100% of all rebates received (before applying cost-sharing), ensuring the $30 limit reflects the lowest possible price. The bill protects rebate information as trade secrets, preventing health plans from disclosing rebate details to the public or third parties. This law applies to all health benefit plans issued, renewed, or continued on or after January 1, 2027.